Dan Staud

AVP, Global Market Access Merck

Dan leads the Global Access Strategy team at Merck.  This team is responsible for the development and operational execution of market access strategies for company in-line and pipeline products covering vaccines, hospital acute care and chronic care franchise areas.  Value communication tools, stakeholder assessments and negotiations plans delivered to the organization ensure a broad understanding of the strategy and any associated access risks that may create potential implications to commercial viability.  Prior to joining Merck, Dan has held roles among a number of different pharmaceutical companies including Pfizer (Wyeth) and GSK whose career has focused on pharmaceutical global value, market access, and pricing opportunities for small-molecule and biologic drugs across a variety of therapeutic areas.